LONDON (Alliance News) - Specialist medical technology company ANGLE PLC said Tuesday that it has taken steps to strengthen its intellectual property covering its Parsortix system. The company has filed claims covering new applications for the Parsortix system, including harvesting blood ce Read More

ANGLE Applies For In Vitro Approval For Parsortix In US

17th Mar 2014 10:34

LONDON (Alliance News) - ANGLE PLC said Monday it has made a submission to the United States Food and Drug Administration for the authorisation of the sale of its Parsortix cell separation system as an in vitro diagnostic device in the United States. The specialist meditech firm has applied Read More

Angle Shares Up On Positive Test Results Using Parsortix

24th Feb 2014 10:47

LONDON (Alliance News) - Shares in ANGLE PLC rose 6.7% Monday after it saw positive results using its Parsortix system to analyse Circulating Tumour Cells in the blood of metastatic liver cancer patients. The test, undertaken by Hari Nageswaran at the University of Surrey's Oncology departm Read More

UK MIDDAY BRIEFING: Inflation Below Target For First Time In 4 Years

18th Feb 2014 12:41

LONDON (Alliance News) - The UK's inflation rate has fallen below the Bank of England's 2% target for the first time in more than four years Tuesday, a decrease that will support governor Mark Carney's recent prediction that the bank's interest rate won't rise for some time to come.<br /><br / Read More

UK WINNERS & LOSERS: Randgold, Goldstone Fall As Drilling Results Disappoint

18th Feb 2014 11:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday. ------- FTSE 100 - WINNERS BHP Billiton, up 1.2%. The Anglo-Australian mining giant has reported an 83% increase in profit for the first half of fiscal Read More

ANGLE To Launch Parsortix At Berlin Medical Conference Wednesday

18th Feb 2014 09:30

LONDON (Alliance News) - Shares in ANGLE PLC were on the rise Tuesday morning, after the specialist med-tech company said it will launch its Parsortix non-invasive cancer diagnostic system at a science and medical researcher conference in Berlin on Wednesday. ANGLE's pretax loss widened in Read More

FTSE 100 Latest

Value8,333.13

Change57.47